News Tag: research results
Combined Cediranib and Olaparib Presents Similar Activity to Standard of Care Treatment for Platinum-Sensitive Ovarian Cancer
Read More
Trastuzumab Achieves Slight Reduction in Recurrence for Women with HER2-Positive Ductal Carcinoma in Situ on NRG Oncology Trial NSABP B-43
Read More
Intensity Modulated Radiotherapy Improved Patient-Reported Outcomes on NRG Oncology Clinical Trial
Read More
NRG Oncology Trial Shows Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastases Reduces Risks of Cognitive Toxicity and Neurologic Symptoms
Read More
NRG Oncology trial shows immunotherapy is safe following chemoradiotherapy for women with node-positive cervical cancer
Read More
Breast-conserving treatment without surgery not supported at this time: Results of NRG Oncology study BR005
Read More
NRG Oncology Trial shows that standard of care chemoradiation for Stage III non-small cell lung cancer is superior to two tested alternatives
Read More
Extended letrozole therapy improves disease-free survival (DFS) in postmenopausal women with HR+ breast cancer: 10-year results of NRG Oncology/NSABP B-42 trial
Read More
Trametinib Improves Outcomes for Women with Low-Grade Serous Carcinoma of the Ovary/Peritoneum on NRG Oncology Trial
Read More
Reduced-Dose Intensity-Modulated Radiotherapy with Cisplatin Meets Predetermined Benchmarks for Progression-Free Survival and Swallowing-Related Quality of Life for Oropharyngeal Cancer
Read More